0001179110-14-017086.txt : 20141125
0001179110-14-017086.hdr.sgml : 20141125
20141125170819
ACCESSION NUMBER: 0001179110-14-017086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141121
FILED AS OF DATE: 20141125
DATE AS OF CHANGE: 20141125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOSPIRA INC
CENTRAL INDEX KEY: 0001274057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 FIELD DR
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 8479376472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH BRIAN J
CENTRAL INDEX KEY: 0001288288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31946
FILM NUMBER: 141250453
MAIL ADDRESS:
STREET 1: 275 NORTH FIELD DRIVE
STREET 2: DEPT NLEG, BLDG H1-4S
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
edgar.xml
FORM 4 -
X0306
4
2014-11-21
0
0001274057
HOSPIRA INC
HSP
0001288288
SMITH BRIAN J
C/O HOSPIRA, INC.
275 NORTH FIELD DRIVE
LAKE FOREST
IL
60045
0
1
0
0
SVP and Special Counsel
Common Stock
2014-11-21
4
M
0
48300
32.470
A
100935
D
CommonStock
2014-11-21
4
S
0
48300
59.340
D
52635
D
Common Stock
2014-11-21
4
M
0
1300
41.900
A
53935
D
Common Stock
2014-11-21
4
S
0
1300
59.134
D
52635
D
Common Stock
2014-11-24
4
M
0
1700
32.47
A
54335
D
Common Stock
2014-11-24
4
S
0
1700
59.000
D
52635
D
Common Stock
2014-11-24
4
M
0
33700
41.90
A
86335
D
Common Stock
2014-11-24
4
S
0
33700
59.305
D
52635
D
Common Stock
2014-11-24
4
M
0
38000
43.18
A
90635
D
Common Stock
2014-11-24
4
S
0
38000
59.019
D
52635
D
Common Stock
2014-11-24
4
M
0
62700
22.150
A
115335
D
Common Stock
2014-11-24
4
S
0
62700
59.482
D
52635
D
Common Stock
9707
I
See note 4.
Stock Options (Right to Buy)
32.470
2014-11-21
4
M
0
48300
0
A
2015-05-08
Common Stock
48300
1700
D
Stock Option (Right to Buy)
41.90
2014-11-21
4
M
0
1300
0
A
2016-05-16
Common Stock
1300
33700
D
Stock Options (Right to Buy)
32.470
2014-11-24
4
M
0
1700
0
A
2015-05-08
Common Stock
1700
0
D
Stock Options
41.900
2014-11-24
4
M
0
33700
0
A
2016-05-16
Common Stock
33700
0
D
Stock Options
43.180
2014-11-24
4
M
0
38000
0
A
2015-03-05
Common Stock
38000
0
D
Stock Options (right to buy)
22.150
2014-11-24
4
M
0
62700
0
A
2016-03-04
Common Stock
62700
0
D
The stock options, granted on May 9, 2005, vested in three equal installments on May 9, 2006, 2007, and 2008. The exercise price of $32.470 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 8, 2015.
Exercise of derivative security exempted pursuant to Rule 16b-3.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
Balance in the qualified Hospira 401(k) Retirement Savings Plan, as of November 25, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.13 to $59.14, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The stock options, granted on May 17, 2006, vested in three equal installments on May 17, 20067 2008, and 2009. The exercise price of $41.900 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 16, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.24 to $59.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.16, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.40 to $59.51, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The stock options, granted on March 6, 2008, vested in three equal installments on March 6, 2009, 2010, and 2011. The exercise price of $43.180 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 5, 2015.
The stock options, granted on March 5, 2009, vested in three equal installments on March 5, 2010, 2011, and 2012. The exercise price of $22.150 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 4, 2016.
Benjamin Kwakye, Attorney in Fact
2014-11-25